Compare ZLAB & DNOW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ZLAB | DNOW |
|---|---|---|
| Founded | 2013 | 1862 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Metal Fabrications |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.4B | 2.4B |
| IPO Year | 2017 | 2014 |
| Metric | ZLAB | DNOW |
|---|---|---|
| Price | $18.35 | $13.22 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 3 |
| Target Price | ★ $49.60 | $16.67 |
| AVG Volume (30 Days) | 598.6K | ★ 2.8M |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 38.46 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $460,156,000.00 | ★ $2,648,000,000.00 |
| Revenue This Year | $9.75 | $69.47 |
| Revenue Next Year | $26.03 | $8.01 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | 15.33 | ★ 25.68 |
| 52 Week Low | $15.96 | $10.94 |
| 52 Week High | $44.34 | $17.26 |
| Indicator | ZLAB | DNOW |
|---|---|---|
| Relative Strength Index (RSI) | 35.16 | 58.78 |
| Support Level | $16.88 | $13.05 |
| Resistance Level | $19.64 | $14.36 |
| Average True Range (ATR) | 0.95 | 0.41 |
| MACD | -0.51 | 0.06 |
| Stochastic Oscillator | 0.22 | 68.46 |
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. Zai Lab has a diverse pipeline of potentially first-in-class product candidates developed through in-house R&D and global partnerships. The company has successfully commercialized several products in China, including Zejula, Optune, Qinlock, and Nuzyra, with plans for further expansion The pipeline of proprietary drug candidates of the company includes ZL-1222, ZL-1311, ZL-6201 and many others.
Dnow Inc is a provider of energy and industrial solutions and a distributor of pipe, valves, and fittings (PVF) and pumps, as well as fabrication, assembly, and testing of process and production equipment. It provides a broad mix of products required to build and maintain essential infrastructure and operating equipment across upstream, midstream, gas utilities, downstream, energy transition, and industrial markets, along with value-added supply chain solutions and technical product expertise supported by digital offerings through its DigitalNOW and MRCGO e-commerce platforms. The company operates mainly under the DNOW and MRC brands and has three reportable segments: the United States, which generates the majority of revenue, Canada, and International.